TABLE 1C from Dual Blockade of EP2 and EP4 Signaling is Required for Optimal Immune Activation and Antitumor Activity Against Prostaglandin-Expressing Tumors
Authors:
- Brian J. FrancicaBFBrian J. Francica
- Anja HoltzAHAnja Holtz
- Justine LopezJLJustine Lopez
- David FreundDFDavid Freund
- Austin ChenACAustin Chen
- Dingzhi WangDWDingzhi Wang
- David PowellDPDavid Powell
- Franciele KipperFKFranciele Kipper
- Dipak PanigrahyDPDipak Panigrahy
- Raymond N. DuboisRDRaymond N. Dubois
- Chan C. WhitingCWChan C. Whiting
- Peppi PrasitPPPeppi Prasit
Open Access
- 8 August 2023
- other
- Published by American Association for Cancer Research (AACR)